OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis
Taylor M. Halsey, Anusha Shirwaikar Thomas, Tomo Hayase, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 700
Closed Access | Times Cited: 60
Taylor M. Halsey, Anusha Shirwaikar Thomas, Tomo Hayase, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 700
Closed Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 48
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 48
Fecal microbiota transplantation: current challenges and future landscapes
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 43
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 43
Advances and prospects of biomarkers for immune checkpoint inhibitors
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101621-101621
Open Access | Times Cited: 26
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101621-101621
Open Access | Times Cited: 26
Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
Yun-Jae Kim, Gihyeon Kim, Sujeong Kim, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 8, pp. 1380-1393.e9
Closed Access | Times Cited: 24
Yun-Jae Kim, Gihyeon Kim, Sujeong Kim, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 8, pp. 1380-1393.e9
Closed Access | Times Cited: 24
A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma
Mattia Ballerini, Serena Galié, Punit Tyagi, et al.
Nature Biomedical Engineering (2025)
Open Access | Times Cited: 2
Mattia Ballerini, Serena Galié, Punit Tyagi, et al.
Nature Biomedical Engineering (2025)
Open Access | Times Cited: 2
The role of the gut microbiota in tumor, immunity, and immunotherapy
Yuyan Xie, Fang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Yuyan Xie, Fang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Dissecting mechanisms of fecal microbiota transplantation efficacy in disease
Catherine M. Andary, Kait F. Al, John A. Chmiel, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 3, pp. 209-222
Open Access | Times Cited: 9
Catherine M. Andary, Kait F. Al, John A. Chmiel, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 3, pp. 209-222
Open Access | Times Cited: 9
Novel strategies for modulating the gut microbiome for cancer therapy
Young Seok Cho, Kai Han, Jin Xu, et al.
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115332-115332
Closed Access | Times Cited: 9
Young Seok Cho, Kai Han, Jin Xu, et al.
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115332-115332
Closed Access | Times Cited: 9
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H. Mullish, Blair Merrick, Mohammed Nabil Quraishi, et al.
Journal of Hospital Infection (2024) Vol. 148, pp. 189-219
Open Access | Times Cited: 8
Benjamin H. Mullish, Blair Merrick, Mohammed Nabil Quraishi, et al.
Journal of Hospital Infection (2024) Vol. 148, pp. 189-219
Open Access | Times Cited: 8
Gut microbiome and immune checkpoint inhibitor toxicity
Rik J. Verheijden, Mick J M van Eijs, Fernanda L. Paganelli, et al.
European Journal of Cancer (2025) Vol. 216, pp. 115221-115221
Closed Access | Times Cited: 1
Rik J. Verheijden, Mick J M van Eijs, Fernanda L. Paganelli, et al.
European Journal of Cancer (2025) Vol. 216, pp. 115221-115221
Closed Access | Times Cited: 1
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
A multi-omic assessment of the mechanisms of intestinal microbes used to treat diarrhea in early-weaned lambs
Hongran Guo, Jiuzeng Cui, Qian Li, et al.
mSystems (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 6
Hongran Guo, Jiuzeng Cui, Qian Li, et al.
mSystems (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 6
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H. Mullish, Blair Merrick, Mohammed Nabil Quraishi, et al.
Gut (2024) Vol. 73, Iss. 7, pp. 1-24
Open Access | Times Cited: 5
Benjamin H. Mullish, Blair Merrick, Mohammed Nabil Quraishi, et al.
Gut (2024) Vol. 73, Iss. 7, pp. 1-24
Open Access | Times Cited: 5
The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond
Jessica R. Allegretti, Sahil Khanna, Benjamin H. Mullish, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 885-902
Closed Access | Times Cited: 5
Jessica R. Allegretti, Sahil Khanna, Benjamin H. Mullish, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 885-902
Closed Access | Times Cited: 5
A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: Fecal microbiota transplantation
Yiming Meng, Jing Sun, Guirong Zhang
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104403-104403
Closed Access | Times Cited: 5
Yiming Meng, Jing Sun, Guirong Zhang
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104403-104403
Closed Access | Times Cited: 5
irAE-colitis induced by CTLA-4 and PD-1 blocking were ameliorated by TNF blocking and modulation of gut microbial
Ruiwei Ye, Hao Zheng, Dandan Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116999-116999
Open Access | Times Cited: 5
Ruiwei Ye, Hao Zheng, Dandan Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116999-116999
Open Access | Times Cited: 5
Assessing live microbial therapeutic transmission
Jeremiah J. Faith
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Jeremiah J. Faith
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management
Conrad Russell Y. Cruz, Maria José Albuquerque Santos, Sharada Wali, et al.
Immunotherapy (2025), pp. 1-11
Closed Access
Conrad Russell Y. Cruz, Maria José Albuquerque Santos, Sharada Wali, et al.
Immunotherapy (2025), pp. 1-11
Closed Access
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Jiaao Sun, Shiyan Song, Jiahua Liu, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
Jiaao Sun, Shiyan Song, Jiahua Liu, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
An updated review on immune checkpoint inhibitor-induced colitis: epidemiology, pathogenesis, treatment strategies, and the role of traditional Chinese medicine
Huijing Dong, Yanmei Peng, Xinmeng Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Huijing Dong, Yanmei Peng, Xinmeng Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus
Faming Zhang, Michael A. Kamm, Xia Wu, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
Faming Zhang, Michael A. Kamm, Xia Wu, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
Autoimmune-related adverse events induced by immune checkpoint inhibitors
Yini Sun, Ziyang Zhang, Jia Ke, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102556-102556
Closed Access
Yini Sun, Ziyang Zhang, Jia Ke, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102556-102556
Closed Access
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series
Catriona Harvey, Kazi Nahar, Janet McKeown, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008232-e008232
Open Access | Times Cited: 4
Catriona Harvey, Kazi Nahar, Janet McKeown, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008232-e008232
Open Access | Times Cited: 4
Multi-omics analysis of a fecal microbiota transplantation trial identifies novel aspects of acute graft-versus-host disease pathogenesis
Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1454-1466
Open Access | Times Cited: 4
Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1454-1466
Open Access | Times Cited: 4
